Search Within

Alison N Gencarelli

Formats
  1. Meeting Abstract (9)
  2. Journal Article (5)
Groups
  1. Nursing (14)
  2. Center for Hematologic Malignancies (13)
  3. Department of Medicine (13)
  4. Hematologic Malignancies, Division of (13)
  5. Adult Leukemia (8)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (8)

More Groups

People
  1. David Scheinberg (8)
  2. Mark Weiss (8)
  3. Nicole Lamanna (8)
  4. Peter Maslak (8)
  5. Andrew Zelenetz (6)
  6. Denise Horgan (6)

More People

Years
  1. 2009 (1)
  2. 2007 (1)
  3. 2006 (1)
  4. 2005 (1)
  5. 2004 (3)
  6. 2003 (2)

More Years

Publications
  1. Blood (9)
  2. Journal of Clinical Oncology (3)
  3. American Journal of Hematology (1)
  4. Annals of Oncology (1)
Publishers
  1. American Society of Hematology (9)
  2. American Society of Clinical Oncology (3)
  3. John Wiley & Sons, Inc. (1)
  4. Oxford University Press (1)

Results (14)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: Molecular remissions predict for durable complete responses
    Journal Article

    Lamanna, N.; Jurcic, J. G.; Noy, A.; Maslak, P.; Gencarelli, A. N.; Panageas, K. S.; Heaney, M. L.; Brentjens, R. J.; Golde, D. W.; Scheinberg, D. A.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Maintaining the dose intensity of ICE chemotherapy with a thrombopoietic agent, PEG-rHuMGDF, may confer a survival advantage in relapsed and refractory aggressive non-Hodgkin lymphoma
    Journal Article

    Moskowitz, C. H.; Hamlin, P. A.; Gabrilove, J.; Bertino, J. R.; Portlock, C. S.; Straus, D. J.; Gencarelli, A. N.; Nimer, S. D.; Zelenetz, A. D.
    Annals of Oncology (2007)

    Fulltext@MSK | Save
  • Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia
    Journal Article

    Lamanna, N.; Kalaycio, M.; Maslak, P.; Jurcic, J. G.; Heaney, M.; Brentjens, R.; Zelenetz, A. D.; Horgan, D.; Gencarelli, A.; Panageas, K. S.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Pentostatin, cyclophosphamide, and rituximab (PCR) has comparable activity but appears to be better tolerated than fludarabine, cyclophosphamide, and rituximab (FCR) in patients with previously treated chronic lymphocytic leukemia
    Meeting Abstract

    Lamanna, N.; Kalaycio, M.; Maslak, P.; Heaney, M. L.; Brentjens, R.; Jurcic, J.; Biederman, E.; Gencarelli, A. N.; Panageas, K. S.; Scheinberg, D. A.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Pentostatin and cyclophosphamide compared to pentostatin, cyclophosphamide, and rituximab as salvage therapy for patients with chronic lymphocytic leukemia
    Meeting Abstract

    Weiss, M. A.; Lamanna, N.; Kalaycio, M.; Jurcic, J.; Maslak, P.; Gencarelli, A.; Scheinberg, D.; Horgan, D.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Pentostatin and cyclophosphamide with or without rituximab has significant activity in patients with previously treated chronic lymphocytic leukemia and other low grade lymphoid neoplasms
    Meeting Abstract

    Lamanna, N.; Kalaycio, M.; Maslak, P.; Jurcic, J.; Scheinberg, D. A.; Gencarelli, A. N.; Horgan, D.; Weiss, M. A.
    Blood (2004)

    Fulltext@MSK | Save
  • Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma
    Journal Article

    Kewalramani, T.; Zelenetz, A. D.; Nimer, S. D.; Portlock, C.; Straus, D.; Noy, A.; O'connor, O.; Filippa, D. A.; Teruya-Feldstein, J.; Gencarelli, A.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Pentostatin, cydophosphamide, and rituximab (PCR therapy): A new active regimen for previously treated patients with chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Weiss, M. A.; Lamanna, N.; Jurcic, J. G.; Maslak, P. G.; Vonhassel, M.; Horgan, D.; Scheinberg, D. A.; Gencarelli, A. N.
    Blood (2003)

    Fulltext@MSK | Save
  • Sequential therapy with fludarabine, high dose cyclophosphamide, and rituximab induces a high incidence of complete response in patients with chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Lamanna, N.; Weiss, M. A.; Maslak, P. G.; Gencarelli, A. N.; Scheinberg, D. A.; Horgan, D.
    Blood (2003)

    Fulltext@MSK | Save
  • Sequential therapy with fludarabine, high dose cyclophosphamide, and rituximab improves the quality of response in patients with previously untreated chronic lymphocytic leukemia
    Meeting Abstract

    Weiss, M. A.; Lamanna, N.; Gencarelli, A.; Scheinberg, D. A.; Maslak, P. G.; Horgan, D.
    Blood (2002)

    Fulltext@MSK | Save